Neuronal Signaling

Shop By

Items 1-50 of 115

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. mAChR antagonist

    Atropine is a competitive antagonist for the muscarinic acetylcholine receptor types M1, M2, M3, M4 and M5.
  2. muscarinic receptor antagonist

    Biperiden hydrochloride is a muscarinic receptor antagonist that displays some selectivity for the M1 subtype
  3. NMDA antagonist

    Non-opioid analgesic with muscle relaxant properties.
  4. AChR antagonist

    Fesoterodine fumarate is a medicine which is used in urinary urgency, reducing the frequency of passing urine and urge urinary incontinence
  5. Benzodiazepine antagonist

    Flumazenil, an imidazobenzodiazepine derivative, antagonizes the actions of benzodiazepines on the central nervous system. Flumazenil competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex. Flumazenil is a weak partial agonist in some animal models of activity, but has little or no agonist activity in humans.
  6. mAChR M2 antagonist

    Gallamine Triethiodide is a mAChR M2 antagonist with pronounced cardioselectivity.
  7. Ipratropium bromide is a muscarinic antagonist, bronchodilator, N-Isopropyl salt of atropine.
  8. α-adrenergic (AR) antagonist/CaM inhibitor

    Phenoxybenzamine is a cell-permeable, non-specific, irreversible α-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
  9. AchR antagonist

    Rocuronium Bromide is a competitive AchR antagonist, used in modern anaesthesia.
  10. muscarinic receptor antagonist

    SVT-40776 is a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
  11. muscarinic acetylcholine receptor (mAChR) antagonist

    Tiotropium Bromide (BA679 BR) is a muscarinic acetylcholine receptor (mAChR) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel.
  12. muscarinic receptor antagonist

    Tolterodine tartrate (Detrol LA) is a muscarinic receptor antagonist which is used for the treatment of urinary incontinence.
  13. muscarinic receptor antagonist

    5-hydroxymethyl tolterodine is a metabolite of Tolterodine, a muscarinic receptor antagonist used in the treatment of urinary incontinence.

  14. muscarinic M3 receptor antagoinst

    Solifenacin-succinate is a muscarinic M3 receptor antagoinst, used in treatment of urinary incontinence.
  15. P2Y12 antagonist

    Ticagrelor (AZD6140) is the first reversibly binding oral P2Y(12) receptor antagonist that blocks ADP-induced platelet aggregation.
  16. P2X7 receptor antagonist

    A 740003 is a novel competitive antagonist of P2X7 receptors (IC50 values = 40 nM for human and 18 nM for rat).
  17. P2Y6 Receptor Antagonist

    MRS 2578 is a selective antagonist of P2Y6 nucleotide receptors
  18. NMDA receptor antagonist

    Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
  19. NMDA receptor antagonist

    Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
  20. Felbamate is an antagonist at the NMDA-associated glycine binding site.
  21. NMDA Receptor Antagonist

    TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
  22. P2X1 antagonist

    NF279 is a suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC50/KB ~ 1 μM in smooth muscle).
  23. acetylcholine receptor antagonist

    Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
  24. P2X3 and P2X2/3 receptor antagonist

    A-317491 sodium salt hydrate is a non-nucleotide P2X3 and P2X2/3 receptor antagonist, which inhibits calcium flux mediated by the receptors.
  25. NMDA receptor antagonist

    SDZ 220-581 is a competitive NMDA receptor antagonist (pKi = 7.7).
  26. GABAA antagonist

    (+)-Bicuculline is a classical GABAA antagonist.
  27. P2X7 receptor antagonist

    A-438079 HCl is a competitive P2X7 receptor antagonist (pIC50 = 6.9 for the inhibition of Ca2+ influx in the human recombinant P2X7 cell line). Devoid of activity at other P2 receptors (IC50 >> 10 uM).
  28. GABAA receptor antagonist

    Gabazine is a selective and competitive antagonist of GABAA receptor, with an IC50 of ~0.2 μM for GABA receptor.
  29. muscarinic antagonist

    Glycopyrrolate is a muscarinic competitive antagonist used as an antispasmodic.
  30. NMDA receptor antagonist

    (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
  31. muscarinic AChR antagonist

    Flavoxate binds and inhibits muscarinic receptors, thereby suppressing the micturition reflex and increases urinary bladder capacity by modifying the micturition center in the brain stem.
  32. NMDA antagonist

    Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
  33. P2X3/P2X2/3 receptor antagonist

    AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, inhibits human and rat P2X3 (pIC50= 8.0).
  34. NMDA receptor antagonist

    RPR104632 is a specific antagonist of NMDA receptor, with potent neuroprotective properties.
  35. NMDA receptor antagonist.

    (-)-MK 801 maleate acts as a potent, selective, and non-competitive NMDA receptor antagonist. It acts by binding to a site located within the NMDA associated ion channel.
  36. NMDA receptor antagonist

    GV-196771A is the sodium salt form of GV196771, is an NMDA receptor antagonist.
  37. muscarinic M(3) receptor antagonist

    PF-3635659 is a potent muscarinic M(3) receptor antagonist.
  38. GABAB receptors antagonist

    2-Hydroxysaclofen is a potent and selective antagonist at GABAB receptors.
  39. NMDA receptor antagonist

    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
  40. mAChR antagonist

    AF-DX 384 is a drug which acts as a selective antagonist of the muscarinic acetylcholine receptors.
  41. NMDA receptor ion channel antagonist

    ARL-15896 is a novel N-methyl-D-aspartate receptor ion channel antagonist.
  42. NMDA receptor antagonist

    DNQX is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
  43. GABA antagonist

    Cloflubicyne is a potent non-competitive GABA antagonist, convulsant, laboratory insecticide.
  44. NMDA receptors antagonist

    NVP-AAM077 inhibited progenitor cells proliferation in the subventricular zone and dentate gyrus and reduced the survival of newborn cells in the dentate gyrus in the adult mice.
  45. M2/M3 antagonist

    Diphenidol HCl is a potent antagonist of muscarinic M2 and M3 receptor with pKb of 6.72 and 7.02.
  46. benzodiazepine receptor antagonist

    Ro 15-1788 is a benzodiazepine receptor antagonist.
  47. 5-HT3 receptor antagonist

    Tropisetron is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ?? 0.9 nM for 5-HT3 receptor.
  48. P2X7 receptor antagonist

    A 438079 Hcl is a competitive P2X7 receptor antagonist (pIC50 = 6.9 for the inhibition of Ca2+ influx in the human recombinant P2X7 cell line).
  49. NMDA receptor antagonist

    SDZ 220-581 ammonium salt is a potent, competitive antagonist at the NMDA glutamate receptor subtype(pKi= 7.7).
  50. Muscarinic receptor antagonist

    Umeclidinium bromide(GSK573719A) is a muscarinic receptor antagonist which is useful in treatment of chronic obstructive pulmonary disease (COPD).

Items 1-50 of 115

Page
per page
Set Descending Direction